Technische Universität Dresden - Center for Regenerative Therapies Dresden (CRTD)
The TU Dresden is one of eleven German universities that were identified as an “excellence university”. TUD has about 36.500 students and almost 5319 employees, 507 professors among them, and, thus, is the largest university in Saxony, today.
Having been committed to sciences and the engineering before the reunification of Germany, TU Dresden now is a multi-discipline university, also offering humanities and social sciences as well as medicine.
Leader of an Independent Junior Research Group on Regenerative Biology
(subject to personal qualification, remuneration according to salary group E 15 TV-L with Tenure-Track to W2)
The position is starting as soon as possible. The position is initially limited to six years according to the Wissenschaftszeitvertragsgesetz – WissZeitVG (Fixed Term Research Contracts Act) and aims at obtaining further academic qualification. Competitive funding will be provided for the position of the junior research group leader and their group, depending on qualification and subject to negotiation. At the latest in the fifth year, a tenure evaluation will be carried out by an inter-faculty and inter-departmental commission. Provided a positive evaluation result, the successful candidate will be appointed to a permanent Chair (W2) of Regenerative Biology without new selection process. The evaluation procedure is based on mutually agreed evaluation criteria at the start of the service. Essential components of the evaluation are the scientific success in the form of quality and quantity of publications, success in the acquisition and management of third-party funds and in the promotion of young academics, a positively evaluated teaching performance, active participation in cooperative projects within and outside the central academic unit and university, and active participation in academic self-administration.
The CMCB unites the three institutes Center for Molecular Bioengineering (B CUBE), Biotechnology Center (BIOTEC) and the CRTD under one roof. Here, interdisciplinarity, innovation and internationality are emphasized. The institutes significantly shape the research profile line "Health Sciences, Biomedicine and Bioengineering" of the TU Dresden. Tissue regeneration and the development of cell-based regenerative therapies are the research topics of the CRTD. Hematology, immunology, diabetes, bone regeneration and neurodegenerative diseases are the main focus. Currently, 20 chairs and research groups with 250 employees from 30 nations are conducting research at the CRTD.